Flywheel resistance exercise to maintain muscle oxidative potential during unloading

Aviat Space Environ Med. 2014 Jul;85(7):694-9. doi: 10.3357/asem.3856.2014.

Abstract

Background: As spaceflight compromises skeletal muscle oxidative and aerobic work capacity, this study assessed the efficacy of resistance exercise (RE) to counteract muscle metabolic perturbations induced by 5 wk unilateral lower limb unloading (UL).

Methods: There were 21 men and women (30-56 yr) who were randomly assigned to either UL with (Group, Grp; UL+RE; N = 10) or without (Grp UL; N = 11) concurrent RE. Iso-inertial RE comprised four sets of seven maximal coupled concentric-eccentric knee extensions executed 2-3 times per week. Percutaneous biopsies were obtained from m. vastus lateralis before and after either intervention. Levels of mRNA expression of factors regulating skeletal muscle oxidative capacity i.e., peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1alpha) and vascular endothelial growth factor (VEGF), and glycolytic capacity, i.e., phosphofructokinase (PFK), glycogen phosphorylase and synthase, hexokinase, and phosphorylase kinase alpha1, were subsequently analyzed.

Results: Grp UL showed decreased (36%) PGC-1alpha expression, increased (1.5-fold) PFK expression, and a trend toward decreased VEGF post-intervention. Grp UL+RE showed no changes.

Discussion: These results suggest that 5 wk unloading reduces skeletal muscle oxidative capacity and increases glycolytic enzyme activity. More importantly, only 12 bouts of high-force, low-volume resistance exercise attenuated these responses. Thus, the current resistance exercise paradigm emphasizing eccentric overload effectively counteracts unwarranted metabolic alterations induced by 5 wk unloading and may, therefore, aid in maintaining skeletal muscle integrity and endurance, and hence astronaut health and fitness during spaceflight.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Analysis of Variance
  • Biopsy, Needle
  • Female
  • Gene Expression Regulation*
  • Glycogen Phosphorylase / genetics
  • Glycogen Phosphorylase / metabolism
  • Glycogen Synthase / genetics
  • Glycogen Synthase / metabolism
  • Hexokinase / genetics
  • Hexokinase / metabolism
  • Humans
  • Lower Extremity
  • Male
  • Middle Aged
  • Muscle, Skeletal / metabolism*
  • Muscle, Skeletal / pathology
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • Phosphofructokinases / genetics
  • Phosphofructokinases / metabolism
  • Phosphorylase Kinase / genetics
  • Phosphorylase Kinase / metabolism
  • RNA, Messenger / metabolism
  • Resistance Training*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Weightlessness Simulation*

Substances

  • PPARGC1A protein, human
  • Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
  • RNA, Messenger
  • Transcription Factors
  • Vascular Endothelial Growth Factor A
  • Glycogen Phosphorylase
  • Glycogen Synthase
  • Phosphofructokinases
  • Hexokinase
  • Phosphorylase Kinase